Maximilian Diehn, MD

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

17 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Diehn’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

17 of 17 plans

Sort by

Plans whose provider directory lists this clinician

Alignment Health BreathEasy (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Clarity (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Harmony (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Honor+ Plan (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health My Choice CalCare (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Silicon (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health smartHMO (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health the ONE (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
SCAN Balance (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN Classic (HMO)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN MyChoice (HMO)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN Strive (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026
DualConnect (HMO D-SNP)	Santa Clara Family Health Plan	Listed	Sep 1, 2026

California Medical Board record

Licence A92153 · Current

Licensed to practise in California · since 2005 · expires 2027-07-31 · Stanford University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Stanford Health Care

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	5.31 (4.24 to 6.37) · 8,661 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	14.1 (12.7 to 15.7) · 2,191 cases	Worse	Jan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths	4.08 (1.95 to 6.21) · 5,296 cases	Better	Jul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.317	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.446	Better	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.241	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.7 (0.6 to 0.9) · 3,348 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.06 (0.45 to 1.67) · 5,374 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.86 (0.72 to 1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	166.09 (137.88 to 194.3) · 470 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.1 · 192 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6.4 · 146 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	9.7 · 253 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.3 · 880 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 935 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	8.7 · 501 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.1 · 7,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.13 (0 to 0.27) · 20,799 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.14 to 0.43) · 23,182 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.94 (0.2 to 1.68) · 5,694 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.36 (1.54 to 3.19) · 7,846 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.2 (3.76 to 6.64) · 5,603 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.38 (0.23 to 2.53) · 2,211 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.52 (0.21 to 0.83) · 19,915 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.6 · 416 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.869	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.857	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.368	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16.2 · 247 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20.5 · 1,021 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	47.8 · 258 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-1.6 · 990 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	20.8 · 976 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.5 · 959 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (4.4 to 6.2) · 2,191 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.1 · 425 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	9.6 · 158 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	19.6 · 183 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.7 (10.4 to 15.4) · 4,578 cases	No different	Jan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at Stanford Health Care

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at Stanford Health Care

Room was "always" clean	75%
Nurses "always" communicated well	82%
Doctors "always" communicated well	81%
Staff "always" explained	63%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	89%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	79%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	83%
Staff "always" explained possible side effects	50%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$9,539

Medicare paid this office $9,539 for 54 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Ct guidance for insertion of radiation therapy fields	20	$829	$41

Who their Medicare patients are

54 Original Medicare patients in 2024. Average age 75 · Women 57% · Health risk score 1.88. Above the middle of the specialty; the typical radiation oncology clinician is at 1.69.

Conditions among them: Cancer 72% · High blood pressure 67% · Chronic kidney disease 33% · Diabetes 24% · Coronary heart disease 20%.

The office billed $108,506, Medicare allowed $12,429 and paid $9,539; for 88 services of 17 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	54	88	75	1.88	$108,506	$9,539
2023	83	282	76	2.26	$416,037	$37,347
2022	74	357	75	2.11	$378,083	$36,834
2021	106	423	76	2.35	$474,903	$46,780
2020	120	485	75	2.09	$572,766	$51,532
2019	86	451	75	2.52	$298,770	$46,089
2018	111	528	74	2.24	$437,379	$58,861
2017	134	571	74	2.11	$398,742	$56,505
2016	85	483	74	2.01	$334,910	$46,703
2015	65	553	73	2.66	$435,879	$55,765
2014	69	626	73	2.51	$423,875	$58,738
2013	74	595	74	2.40	$340,720	$48,717

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 10 services

Sort by

Original Medicare services billed in 2023

High precision radiation therapy planning	19	$7,318	$385
Management of cranial lesion surgery using radiation over multiple sessions	12	$7,277	$606
Return visit (30+ min)	41	$5,488	$90
Design and construction of radiation treatment device for high precision radiation therapy	19	$4,311	$216
Complex radiation therapy planning	17	$2,703	$159
Obtaining respiratory data needed to develop the optimal radiation treatment	17	$1,708	$100
Ct guidance for insertion of radiation therapy fields	17	$1,409	$43
Design and construction of complex radiation treatment device	17	$1,040	$55
Calculation of radiation therapy dose	19	$874	$31
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy	14	$449	$20

2022: 8 services

Sort by

Original Medicare services billed in 2022

Return visit (30+ min)	40	$6,615	$89
High precision radiation therapy planning	13	$5,551	$397
Ct guidance for insertion of radiation therapy fields	26	$4,857	$42
Design and construction of radiation treatment device for high precision radiation therapy	13	$3,194	$213
Complex radiation therapy planning	15	$2,511	$157
Obtaining respiratory data needed to develop the optimal radiation treatment	13	$1,393	$100
Design and construction of complex radiation treatment device	14	$1,084	$57
Calculation of radiation therapy dose	14	$739	$31

2021: 15 services

Sort by

Original Medicare services billed in 2021

Management of cranial lesion surgery using radiation over multiple sessions	14	$8,452	$604
High precision radiation therapy planning	17	$7,195	$400
Return visit (30+ min)	43	$5,421	$89
Design and construction of radiation treatment device for high precision radiation therapy	18	$4,502	$214
Radiation treatment management, 5 treatment sessions	14	$3,790	$180
Ct guidance for insertion of radiation therapy fields	38	$3,377	$40
Complex radiation therapy planning	19	$2,781	$146
New patient visit (60+ min)	11	$1,727	$157
Design and construction of complex radiation treatment device	24	$1,609	$54
Long return visit (40+ min)	12	$1,601	$123
Obtaining respiratory data needed to develop the optimal radiation treatment	14	$1,505	$100
Special radiation treatment	11	$1,123	$102
Calculation of radiation therapy dose	20	$1,053	$30
Short return visit (20+ min)	17	$1,026	$57
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy	20	$823	$19

2020: 13 services

Sort by

Original Medicare services billed in 2020

High precision radiation therapy planning	21	$8,937	$406
Management of cranial lesion surgery using radiation over multiple sessions	12	$7,366	$614
Design and construction of radiation treatment device for high precision radiation therapy	21	$5,239	$218
Ct guidance for insertion of radiation therapy fields	29	$5,120	$43
Return visit (30+ min)	43	$4,228	$73
Complex radiation therapy planning	21	$3,535	$161
Obtaining respiratory data needed to develop the optimal radiation treatment	19	$1,942	$102
Special radiation treatment	18	$1,862	$103
New patient visit (60+ min)	11	$1,735	$158
Design and construction of complex radiation treatment device	23	$1,527	$59
Calculation of radiation therapy dose	21	$1,104	$32
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy	32	$1,025	$20
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area	18	$688	$36

2019: 11 services

Sort by

Original Medicare services billed in 2019

High precision radiation therapy planning	16	$7,434	$391
Design and construction of radiation treatment device for high precision radiation therapy	18	$4,833	$210
Ct guidance for insertion of radiation therapy fields	21	$4,655	$40
Return visit (30+ min)	45	$4,234	$71
Complex radiation therapy planning	24	$3,844	$154
New patient visit (60+ min)	16	$2,437	$152
Special radiation treatment	22	$2,286	$99
Obtaining respiratory data needed to develop the optimal radiation treatment	16	$1,765	$98
Design and construction of complex radiation treatment device	22	$1,252	$50
Calculation of radiation therapy dose	18	$1,005	$30
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy	16	$502	$19

2018: 15 services

Sort by

Original Medicare services billed in 2018

Management of cranial lesion surgery using radiation over multiple sessions	18	$10,344	$575
High precision radiation therapy planning	24	$9,559	$368
Radiation treatment management, 5 treatment sessions	18	$6,342	$167
Return visit (30+ min)	51	$6,146	$70
Design and construction of radiation treatment device for high precision radiation therapy	23	$5,329	$205
Complex radiation therapy planning	25	$4,253	$147
Ct guidance for insertion of radiation therapy fields	23	$3,104	$40
New patient visit (60+ min)	20	$3,010	$151
Special radiation treatment	22	$2,320	$97
Obtaining respiratory data needed to develop the optimal radiation treatment	21	$2,193	$95
Design and construction of complex radiation treatment device	24	$1,767	$52
Long return visit (40+ min)	12	$1,324	$95
Calculation of radiation therapy dose	25	$1,243	$30
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy	26	$876	$19
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area	17	$571	$32

2017: 13 services

Sort by

Original Medicare services billed in 2017

Management of cranial lesion surgery using radiation over multiple sessions	14	$9,102	$569
Return visit (30+ min)	57	$8,884	$68
High precision radiation therapy planning	21	$8,677	$377
Design and construction of radiation treatment device for high precision radiation therapy	21	$4,653	$202
New patient visit (60+ min)	27	$3,977	$147
Complex radiation therapy planning	22	$3,438	$149
Ct guidance for insertion of radiation therapy fields	21	$2,647	$40
Special radiation treatment	21	$2,115	$96
Obtaining respiratory data needed to develop the optimal radiation treatment	19	$1,896	$95
Design and construction of complex radiation treatment device	27	$1,722	$52
Calculation of radiation therapy dose	25	$1,684	$30
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy	38	$1,302	$19
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area	16	$696	$33

2016: 12 services

Sort by

Original Medicare services billed in 2016

High precision radiation therapy planning	20	$8,608	$374
Return visit (30+ min)	40	$5,618	$67
Design and construction of radiation treatment device for high precision radiation therapy	20	$4,618	$201
Ct guidance for insertion of radiation therapy fields	19	$2,856	$40
New patient visit (60+ min)	19	$2,845	$150
Complex radiation therapy planning	19	$2,814	$148
Design and construction of complex radiation treatment device	22	$1,802	$58
Obtaining respiratory data needed to develop the optimal radiation treatment	16	$1,690	$94
Special radiation treatment	17	$1,662	$98
Calculation of radiation therapy dose	22	$1,427	$29
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area	18	$1,308	$31
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy	17	$673	$18

2015: 12 services

Sort by

Original Medicare services billed in 2015

Management of cranial lesion surgery using radiation over multiple sessions	19	$11,147	$557
High precision radiation therapy planning	23	$8,492	$369
Return visit (30+ min)	47	$5,285	$66
Design and construction of radiation treatment device for high precision radiation therapy	23	$4,567	$199
Complex radiation therapy planning	26	$3,807	$146
New patient visit (60+ min)	17	$2,431	$143
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area	22	$2,166	$32
Design and construction of complex radiation treatment device	28	$1,868	$57
Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved	22	$1,805	$72
Obtaining respiratory data needed to develop the optimal radiation treatment	19	$1,758	$93
Calculation of radiation therapy dose	25	$1,754	$29
Long return visit (40+ min)	13	$1,389	$99

2014: 15 services

Sort by

Original Medicare services billed in 2014

Radiation treatment management, 5 treatment sessions	14	$9,391	$165
High precision radiation therapy planning	23	$8,850	$369
Management of cranial lesion surgery using radiation over multiple sessions	14	$7,798	$557
Design and construction of radiation treatment device for high precision radiation therapy	26	$5,403	$193
Return visit (30+ min)	39	$4,286	$66
Complex radiation therapy planning	25	$3,803	$146
New patient visit (60+ min)	23	$3,150	$137
Special radiation treatment	24	$2,414	$97
Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved	25	$2,163	$72
Ct guidance for insertion of radiation therapy fields	13	$2,098	$39
Design and construction of complex radiation treatment device	28	$2,060	$56
X-ray guidance for radiation therapy delivery	17	$2,054	$18
Calculation of radiation therapy dose	28	$1,663	$29
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area	16	$1,161	$32
Short return visit (20+ min)	17	$773	$45

2013: 13 services

Sort by

Original Medicare services billed in 2013

Radiation treatment management, 5 treatment sessions	23	$8,228	$158
High precision radiation therapy planning	18	$6,342	$352
Return visit (30+ min)	36	$4,240	$62
Design and construction of radiation treatment device for high precision radiation therapy	18	$3,600	$189
New patient visit (60+ min)	23	$3,243	$141
Complex radiation therapy planning	20	$3,093	$134
Design and construction of complex radiation treatment device	22	$2,930	$51
Calculation of radiation therapy dose	25	$1,963	$25
Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved	20	$1,786	$69
X-ray guidance for radiation therapy delivery	17	$1,750	$17
Special radiation treatment	17	$1,659	$92
Ct guidance for insertion of radiation therapy fields	14	$1,310	$37
Short return visit (20+ min)	22	$1,051	$44

Money from drug and device companies

$6,465 in 2025

Sort by

Industry payments by year

2025	2	2	$6,465	$6,465
2024	1	2	$1,888	$1,938
2023	2	16	$9,276	$15,310
2022	2	7	$10,630	$10,799
2021	5	11	$19,059	$19,187
2020	4	7	$14,175	$14,312
2019	2	3	$5,000	$5,206

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Chugai Pharmaceutical Co.	Tecentriq	$3,280	1 payment Consulting for Tecentriq · 2025-11-13 · $3,280
AstraZeneca UK	Tagrisso	$3,185	1 payment Consulting for Tagrisso · 2025-01-06 · $3,185

See all 2 published payments

Sort by

Every published payment

Chugai Pharmaceutical Co.	Consulting · 2025-11-13	Tecentriq	$3,280
AstraZeneca UK	Consulting · 2025-01-06	Tagrisso	$3,185

See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $1,938

Sort by

Payments by company in 2024

AstraZeneca Pharmaceuticals LP	Tagrisso	$1,938	2 payments Consulting · 2024-11-25 · $1,888 Meals for Tagrisso · 2024-09-09 · $50

2023: $15,310

Sort by

Payments by company in 2023

Regeneron Pharmaceuticals	Libtayo	$15,251	15 payments Consulting for Libtayo · 2023-06-23 · $4,638 Consulting for Libtayo · 2023-06-23 · $4,638 Travel for Libtayo · 2023-06-23 · $47 Travel for Libtayo · 2023-06-23 · $43 Travel for Libtayo · 2023-06-23 · $8 Travel for Libtayo · 2023-05-01 · $140 Travel for Libtayo · 2023-05-01 · $145 Meals for Libtayo · 2023-04-29 · $38 Meals for Libtayo · 2023-04-29 · $72 Meals for Libtayo · 2023-04-29 · $89 Meals for Libtayo · 2023-04-29 · $38 Meals for Libtayo · 2023-04-29 · $125 Travel for Libtayo · 2023-04-28 · $381 Travel for Libtayo · 2023-04-22 · $35 Travel for Libtayo · 2023-04-22 · $4,816
Gilead Sciences	Trodelvy	$59	1 payment Meals for Trodelvy · 2023-09-10 · $59

2022: $10,799

Sort by

Payments by company in 2022

AstraZeneca Pharmaceuticals LP	Tagrisso	$8,305	4 payments Consulting · 2022-12-06 · $1,888 Consulting · 2022-11-01 · $2,643 Consulting for Tagrisso · 2022-07-19 · $2,265 Consulting for Imfinzi · 2022-06-09 · $1,510
AstraZeneca UK	Tagrisso	$2,494	3 payments Meals for Tagrisso · 2022-10-20 · $47 Meals for Tagrisso · 2022-10-20 · $121 Consulting · 2022-07-22 · $2,325

2021: $19,187

Sort by

Payments by company in 2021

AstraZeneca UK	Tagrisso	$6,298	2 payments Consulting for Tagrisso · 2021-05-12 · $5,285 Consulting for Imfinzi · 2021-03-16 · $1,013
Genentech	Tecentriq	$5,775	2 payments Consulting for Tecentriq · 2021-05-20 · $1,980 Consulting · 2021-03-01 · $3,795
Boehringer Ingelheim International GmbH	None	$2,835	1 payment Consulting · 2021-05-12 · $2,835
AstraZeneca Pharmaceuticals LP	Imfinzi	$2,638	5 payments Meals · 2021-12-04 · $18 Meals · 2021-12-04 · $110 Consulting for Tagrisso · 2021-08-12 · $500 Consulting for Imfinzi · 2021-07-07 · $500 Consulting for Imfinzi · 2021-01-06 · $1,510
Novartis Pharmaceuticals	Ilaris	$1,641	1 payment Consulting for Ilaris · 2021-10-20 · $1,641

2020: $14,312

Sort by

Payments by company in 2020

AstraZeneca Pharmaceuticals LP	Tagrisso	$8,495	4 payments Consulting for Tagrisso · 2020-12-22 · $2,643 Consulting · 2020-10-01 · $3,038 Meals · 2020-02-21 · $115 Consulting · 2020-01-16 · $2,700
Genentech	None	$3,795	1 payment Consulting · 2020-12-04 · $3,795
Roche Sequencing Solutions	Sequencing Research & Development	$2,000	1 payment Paid to speak or teach for Sequencing Research & Development · 2020-06-23 · $2,000
Varian Medical Systems	Other	$22	1 payment Meals for Other · 2020-02-14 · $22

2019: $5,206

Sort by

Payments by company in 2019

AstraZeneca Pharmaceuticals LP	None	$5,108	2 payments Travel · 2019-06-04 · $108 Consulting · 2019-05-06 · $5,000
Varian Medical Systems	None	$97	1 payment Meals · 2019-10-12 · $97

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Sort by

Research payments by company and study

Varian Medical Systems, Inc. · Fresolimumab and Sar - Stanford (Genzyme) · 2020	Their institution	$216,667
AstraZeneca Pharmaceuticals LP · Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage Iib III Nsclc · 2025	Their institution	$202,102
AstraZeneca Pharmaceuticals LP · Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage Iib III Nsclc · 2023	Their institution	$188,116
AstraZeneca Pharmaceuticals LP · Personalized Escalation of Consolidation Immunotherapy Following Chemoradiotherapy in Stage III Nsclc · 2022	Their institution	$144,085
AstraZeneca Pharmaceuticals LP · Personalized Escalation of Consolidation Immunotherapy Following Chemoradiotherapy in Stage III Nsclc · 2024	Their institution	$105,541
AstraZeneca Pharmaceuticals LP · Title Not Available in Impact Or Mlcs Description Not Available at Az Clinical Trials · 2021	Their institution	$89,280
AstraZeneca Pharmaceuticals LP · Personalized Escalation of Consolidation Immunotherapy Following Chemoradiotherapy in Stage III Nsclc · 2021	Their institution	$66,830
Varian Medical Systems, Inc. · Fresolimumab and Sar - Stanford Genzyme · 2019	Their institution	$50,000
AstraZeneca Pharmaceuticals LP · Personalized Escalation of Consolidation Immunotherapy Following Chemoradiotherapy in Stage III Nsclc · 2025	Their institution	$41,744
Genentech, Inc. · Analysis of Circulating Tumor Dna for Detection of Minimal Residual Disease in Resected Stage Ib-Iiia Non-Small Cell Lung Cancer Patients From Ecog-Acrin E1505 · 2020	Their institution	$23,683
AstraZeneca Pharmaceuticals LP · A Phase II Study of Combined Treatment of Durvalumab, Bevacizumab and Transarterial Chemoembolization (Tace) in Subjects With Hepatocellular Carcinoma (Hcc) · 2025	Their institution	$960

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score: 76.5 / 100; Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI: 1174719850
Licence: CA A92153California A92153: Current · expires 2027-07-31
Trained: Stanford University School of Medicine, 2004
Group: Stanford Health Care
Video visits: Lists video visits
Gender: Male

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 2085R0001X (2085R0001X)
Mailing address: 875 Blake Wilbur Dr., Dept. of Radiation Oncology (Mc-5847), Stanford, CA, 94305
NPI first listed: 2007-09-17
NPI last updated: 2007-09-17

This is when the NPI record was last certified, not a medical board exam.